StockData
Neuraxis, INC logo

Neuraxis, INC (NRXS) stock

NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 0/30
$4.87+0.26 (+5.64%)

Close on Nov 18, 2026Market cap $61.16MP/E –Yield –

Neuraxis price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Neuraxis's price to sales ratio was 14.1× on Nov 11, 2026, against 8.2× a year earlier. Over the last 3 years it ranged from 1.4× to 22.2×, with a median of 8.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202614.1×+0.8
2025Dec 31, 202513.3×+6.7
2024Dec 31, 20246.7×+1.3
2023Dec 29, 20235.4×–

More Neuraxis figures

See a number that looks wrong?